en
Scientific article
Open access
English

White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers

Published inJournal of Alzheimer's disease, vol. 79, no. 1, p. 163-175
Publication date2021
First online date2021-01-05
Abstract

Background: The cerebrospinal fluid (CSF) biomarkers amyloid-β 1-42 (Aβ42), total and phosphorylated tau (t-tau, p-tau) are increasingly used to assist in the clinical diagnosis of Alzheimer's disease (AD). However, CSF biomarker levels can be affected by confounding factors.

Objective: To investigate the association of white matter hyperintensities (WMHs) present in the brain with AD CSF biomarker levels.

Methods: We included CSF biomarker and magnetic resonance imaging (MRI) data of 172 subjects (52 controls, 72 mild cognitive impairment (MCI), and 48 AD patients) from 9 European Memory Clinics. A computer aided detection system for standardized automated segmentation of WMHs was used on MRI scans to determine WMH volumes. Association of WMH volume with AD CSF biomarkers was determined using linear regression analysis.

Results: A small, negative association of CSF Aβ42, but not p-tau and t-tau, levels with WMH volume was observed in the AD (r2 = 0.084, p = 0.046), but not the MCI and control groups, which was slightly increased when including the distance of WMHs to the ventricles in the analysis (r2 = 0.105, p = 0.025). Three global patterns of WMH distribution, either with 1) a low, 2) a peak close to the ventricles, or 3) a high, broadly-distributed WMH volume could be observed in brains of subjects in each diagnostic group.

Conclusion: Despite an association of WMH volume with CSF Aβ42 levels in AD patients, the occurrence of WMHs is not accompanied by excess release of cellular proteins in the CSF, suggesting that WMHs are no major confounder for AD CSF biomarker assessment.

eng
Keywords
  • Alzheimer’s disease
  • Amyloid
  • Biomarkers
  • Cerebrospinal fluid
  • Magnetic resonance imaging
  • Tau proteins
  • White matter hyperintensities
  • White matter lesions
  • Aged
  • Alzheimer Disease / cerebrospinal fluid
  • Alzheimer Disease / diagnosis
  • Amyloid beta-Peptides / cerebrospinal fluid
  • Cognitive Dysfunction / cerebrospinal fluid
  • Cognitive Dysfunction / diagnosis
  • Confounding Factors, Epidemiologic
  • Female
  • Humans
  • Image Processing, Computer-Assisted
  • Leukoencephalopathies / cerebrospinal fluid
  • Leukoencephalopathies / diagnostic imaging
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Peptide Fragments / cerebrospinal fluid
  • Phosphorylation
  • Tau Proteins / cerebrospinal fluid
Funding
Citation (ISO format)
VAN WAALWIJK VAN DOORN, Linda J C et al. White Matter Hyperintensities Are No Major Confounder for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers. In: Journal of Alzheimer’s disease, 2021, vol. 79, n° 1, p. 163–175. doi: 10.3233/JAD-200496
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
ISSN of the journal1387-2877
21views
4downloads

Technical informations

Creation11/16/2022 9:53:56 AM
First validation08/23/2023 1:42:16 PM
Update time08/23/2023 1:42:16 PM
Status update08/23/2023 1:42:16 PM
Last indexation02/01/2024 10:33:28 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack